Articles: dapsone.

• Latest
• Best
• Search…

• J. Invest. Dermatol. · Apr 2014

  Comment Letter

  Different roads, same destination.

  no abstract available

  explore more… mark as read…

• J. Invest. Dermatol. · Nov 2013

  Letter

  Association between HLA-B*1301 and dapsone-induced hypersensitivity reactions among leprosy patients in China.

  no abstract available

  explore further… or not…

• N. Engl. J. Med. · Oct 2013

  HLA-B*13:01 and the dapsone hypersensitivity syndrome.

  Dapsone is used in the treatment of infections and inflammatory diseases. The dapsone hypersensitivity syndrome, which is associated with a reported mortality of 9.9%, develops in about 0.5 to 3.6% of persons treated with the drug. Currently, no tests are available to predict the risk of the dapsone hypersensitivity syndrome. ⋯ HLA-B*13:01 was associated with the development of the dapsone hypersensitivity syndrome among patients with leprosy. (Funded by the National Natural Science Foundation of China and others.).

  expand abstract… or not…

• J Formos Med Assoc · Oct 2013

  Comment Letter

  Causes of decreased HbA1c levels in a medical center laboratory in Taiwan.

  no abstract available

  expand abstract… or not…

• Neth J Med · May 2013

  Letter Case Reports

  Dapsone for the treatment of chronic IgA vasculitis (Henoch-Schonlein).

  no abstract available

  read more… or just mark as read…